118 related articles for article (PubMed ID: 38438958)
1. Nuclear respiratory factor 1 regulates super enhancer-controlled SPIDR to protect hepatocellular carcinoma cells from oxidative stress.
Liu B; Dou J; Cao J
BMC Gastroenterol; 2024 Mar; 24(1):97. PubMed ID: 38438958
[TBL] [Abstract][Full Text] [Related]
2. Nuclear respiratory factor 1 promotes the growth of liver hepatocellular carcinoma cells via E2F1 transcriptional activation.
Wang D; Wan B; Zhang X; Sun P; Lu S; Liu C; Zhu L
BMC Gastroenterol; 2022 Apr; 22(1):198. PubMed ID: 35448958
[TBL] [Abstract][Full Text] [Related]
3. Nuclear respiratory factor 1 drives hepatocellular carcinoma progression by activating LPCAT1-ERK1/2-CREB axis.
Liu R; Yin C; Zhao P; Guo B; Ke W; Zheng X; Xie D; Wang Y; Wang G; Jia Y; Gao Y; Hu W; Liu GL; Song Z
Biol Direct; 2023 Oct; 18(1):67. PubMed ID: 37875967
[TBL] [Abstract][Full Text] [Related]
4. NRF1 Alleviated Oxidative Stress of Glioblastoma Cells by Regulating NOR1.
Wang J; Chen S; Xiang W; Zhu Q; Ren N
Folia Biol (Praha); 2023; 69(1):13-21. PubMed ID: 37962027
[TBL] [Abstract][Full Text] [Related]
5. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
[TBL] [Abstract][Full Text] [Related]
6. Anchoring super-enhancer-driven oncogenic lncRNAs for anti-tumor therapy in hepatocellular carcinoma.
Yuan XQ; Zhou N; Wang JP; Yang XZ; Wang S; Zhang CY; Li GC; Peng L
Mol Ther; 2023 Jun; 31(6):1756-1774. PubMed ID: 36461633
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species-induced activation of Yes-associated protein-1 through the c-Myc pathway is a therapeutic target in hepatocellular carcinoma.
Cho Y; Park MJ; Kim K; Kim SW; Kim W; Oh S; Lee JH
World J Gastroenterol; 2020 Nov; 26(42):6599-6613. PubMed ID: 33268949
[TBL] [Abstract][Full Text] [Related]
8. Super-enhancer-driven AJUBA is activated by TCF4 and involved in epithelial-mesenchymal transition in the progression of Hepatocellular Carcinoma.
Zhang C; Wei S; Sun WP; Teng K; Dai MM; Wang FW; Chen JW; Ling H; Ma XD; Feng ZH; Duan JL; Cai MY; Xie D
Theranostics; 2020; 10(20):9066-9082. PubMed ID: 32802179
[No Abstract] [Full Text] [Related]
9. The PGC1α/NRF1-MPC1 axis suppresses tumor progression and enhances the sensitivity to sorafenib/doxorubicin treatment in hepatocellular carcinoma.
Wang C; Dong L; Li X; Li Y; Zhang B; Wu H; Shen B; Ma P; Li Z; Xu Y; Chen B; Pan S; Fu Y; Huo Z; Jiang H; Wu Y; Ma Y
Free Radic Biol Med; 2021 Feb; 163():141-152. PubMed ID: 33276082
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress indicated by elevated expression of Nrf2 and 8-OHdG promotes hepatocellular carcinoma progression.
Ma-On C; Sanpavat A; Whongsiri P; Suwannasin S; Hirankarn N; Tangkijvanich P; Boonla C
Med Oncol; 2017 Apr; 34(4):57. PubMed ID: 28281193
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Super-Enhancer Landscape in Human Hepatocellular Carcinoma.
Tsang FH; Law CT; Tang TC; Cheng CL; Chin DW; Tam WV; Wei L; Wong CC; Ng IO; Wong CM
Hepatology; 2019 Jun; 69(6):2502-2517. PubMed ID: 30723918
[TBL] [Abstract][Full Text] [Related]
12. E2F1 combined with LINC01004 super-enhancer to promote hepatocellular carcinoma cell proliferation and metastasis.
Li J; Wang J; Wang Y; Zhao X; Su T
Clin Epigenetics; 2023 Jan; 15(1):17. PubMed ID: 36721155
[TBL] [Abstract][Full Text] [Related]
13. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
14. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.
Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP
World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688
[TBL] [Abstract][Full Text] [Related]
15. Histone chaperone FACT complex mediates oxidative stress response to promote liver cancer progression.
Shen J; Chen M; Lee D; Law CT; Wei L; Tsang FH; Chin DW; Cheng CL; Lee JM; Ng IO; Wong CC; Wong CM
Gut; 2020 Feb; 69(2):329-342. PubMed ID: 31439637
[TBL] [Abstract][Full Text] [Related]
16. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
17. A negative feedback loop between microRNA-378 and Nrf1 promotes the development of hepatosteatosis in mice treated with a high fat diet.
Zhang T; Zhao X; Steer CJ; Yan G; Song G
Metabolism; 2018 Aug; 85():183-191. PubMed ID: 29625129
[TBL] [Abstract][Full Text] [Related]
18. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis and validation of SNX7 as a novel biomarker for the diagnosis, prognosis, and prediction of chemotherapy and immunotherapy response in hepatocellular carcinoma.
Chen J; Gao G; Zhang Y; Dai P; Huang Y
BMC Cancer; 2023 Sep; 23(1):899. PubMed ID: 37743471
[TBL] [Abstract][Full Text] [Related]
20. Differential Yet Integral Contributions of Nrf1 and Nrf2 in the Human HepG2 Cells on Antioxidant Cytoprotective Response against
Wufuer R; Fan Z; Liu K; Zhang Y
Antioxidants (Basel); 2021 Oct; 10(10):. PubMed ID: 34679746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
